Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have been developed to manage type 2 diabetes mellitus. Although, in the last 10 years, the use ofGLP-1RAs, especially semaglutide and liraglutide, has increased, its clinical implications andhowit affects metabolic parameters have yet to be fully consolidated. This narrative review explores the metabolic effects ofGLP-1RAs ...
Jun 1, 2025Abstract Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) have become central in managing obesity and type 2 diabetes, primarily through appetite suppression and metabolic regulation. This review explores the mechanisms underlyingGLP-1RA-induced weight loss, focusing on central and peripheral pathways.
ABSTRACT Glucagon-like peptide-1 (GLP-1) is a 30-amino acid peptide hormone that is mainly expressed in the intestine and hypothalamus. In recent years, basic and clinical studies have shown thatGLP-1is closely related to lipidmetabolism, and it can participate in lipidmetabolismby inhibitingfatsynthesis, promotingfatdifferentiation, enhancing cholesterolmetabolism, and promoting ...
Jan 23, 2025Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) have become central in managing obesity and type 2 diabetes, primarily through appetite suppression and metabolic regulation. This review explores the mechanisms underlyingGLP-1RA-induced weight loss, focusing on central and peripheral pathways. Centrally,GLP-1RAs modulate brain regions controlling appetite, influencing ...
Mar 5, 2025Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have transformed obesity management, offering substantial weight loss and metabolic benefits. This review examines their expanding role, evaluating efficacy compared to alternative treatments, emerging indications, ongoing challenges, and future directions. Beyond obesity and type 2 diabetes, the therapeutic potential ofGLP-1RAs extends ...
Glucagon-like peptide-1 (GLP-1) is a gastrointestinal hormone released in response to meal ingestion and enhances insulin secretion from pancreatic β cells. In several human studies,GLP-1secretory responses to oral glucose load or a meal were decreased in subjects with obesity, glucose intolerance, or diabetes compared with those in healthy subjects. However, the results of meta-analysis ...
Glucagon-like peptide1(GLP-1), a gastrointestinal peptide and central mediator of glucosemetabolism, is secreted by L cells in the intestine in response to food intake. Postprandial secretion ofGLP-1is triggered by nutrient-sensing via transporters and G-protein-coupled receptors (GPCRs).GLP-1secretion may be lower in adults with obesity/overweight (OW) or type 2 diabetes mellitus (T2DM ...
Jun 11, 2025Through this axis,GLP-1stimulates insulin secretion, enhances insulin sensitivity, delays gastric emptying, suppresses appetite, andinfluenceslipidmetabolism[5].
Apr 18, 2025Introduction Glucagon-like peptide-1 (GLP-1) is an incretin hormone that plays a crucial role in the regulation of glucosemetabolismand appetite. Released from the intestines in response to food intake,GLP-1enhances insulin secretion, inhibits glucagon release, and promotes satiety, thereby contributing to the maintenance of glucose ...
The major physiological stimuli ofGLP-1secretion are carbohydrate,fatand protein ingestion, and bile acids 5 (Fig. 2). Stimulation of L cells occurs downstream of food digestion and is closely ...
5 days agoIntroduction to Hormonal Regulation of Weight Hormones likeGLP-1(glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) are key regulators of body weight andmetabolism. These hormonesinfluencehowthe body manages insulin, glucose levels,fatstorage, and appetite.GLP-1and GIP also play an important role in regulating blood glucose levels, which is why they have ...
Gut Health,GLP-1and Weight Management: What the Science Really Says Your gut bacteriainfluencehowyour body produces hunger hormones, processes calories, and storesfat. Here is what 16 peer-reviewed studies reveal about the gut-metabolismconnection.
The Lean Mass Question DuringGLP-1Weight LossGLP-1medications are among the most effective pharmacologic tools currently available for obesity and metabolic disease management. Clinical trials have demonstrated significant improvements in weight, glycemic control, and cardiometabolic risk factors.
Because GIP receptors are found onfatcells butGLP-1receptors are not, tirzepatide has a direct pathway toinfluencefatmetabolismthat semaglutide simply lacks.
Mar 14, 2026GLP1Microdosing and alcohol explained. Learn if drinking is safe duringGLP-1microdose weight loss therapy andhowto avoid side effects while losing weight safely.
7 days agoNaturalGLP-1trigger drinks are quickly becoming one of the biggestmetabolismtrends in 2026.GLP-1, often called the body's "fullness hormone," is released in the gut after eating and helps send signals to the brain that reduce hunger and slow digestion.
5 days agoHealthy habits can make a big difference, but the body'smetabolismis also controlled by a network of hormones, brain signals, genetics and environmental factors that play an important role. New medications calledGLP-1receptor agonists are changinghowdoctors treat obesity.
TodayCME INDIA (@CMEINDIA1). 42 views. ⏰GLP-1RA: From "Glucose Drugs" to Chronometabolic Modulators 📄 🔹 Pearl1—GLP-1is a circadian hormone, not just an incretinGLP-1secretion follows a diurnal rhythm, with higher responses in the morning and reduced secretion later in the day, aligningmetabolismwith feeding cycles. 🔹 Pearl 2 — Circadian disruption = incretin dysfunction ...
4 days agoPlateauing on semaglutide or tirzepatide? Learn why it happens and what clinicians adjust to restart progress.
CanGLP-1medications help Hashimoto's disease? Explore the research on semaglutide, tirzepatide, thyroid autoimmunity, weight loss, and TPO antibodies.
6 days agoHowMenopause ReshapesMetabolismand WhyGLP-1Addresses the Root Causes To understand whyGLP-1medications can be particularly effective for women over 40, it helps to understand what menopause actually does tometabolism. As estrogen levels decline, the body undergoes several significant physiological shifts.
Feb 25, 2026Research is also exploringhowGIP andGLP-1signaling directly impactsfatcells (adipocytes). Some studies suggest these pathways caninfluencehowfatis stored and mobilized for energy.
4 days agoAs interest inGLP-1medications and metabolic health continues to grow, many people are looking for natural ways to support appetite control, blood sugar balance, and body composition. Inspired Nutraceuticals created GLX, a 4-in-1 completeGLP-1support system designed to target multiple pathways involved in hunger,metabolism, and gut health.
GLP-1Weight Loss and Muscle Loss Why Losing Muscle Slows YourMetabolismGLP-1medications such as semaglutide and tirzepatide can absolutely lead to weight loss. But weight loss is not the same asfatloss. When weight drops quickly—especially with appetite suppression—the body does not selectively burnfat. It also gives up lean mass, including skeletal muscle.
4 days ago"Hormones,metabolism, medical conditions, medications, and inherited traits can allinfluencebody weight as well." One of the most effective medication treatments for obesity is a group of medications called glucagon-like peptide-1 (GLP-1) receptor agonists, orGLP-1s.
See exactlyhowmuch weight people lose per month onGLP-1medications like semaglutide and tirzepatide, with clinical trial data and real world results.
2 days agoIn depth, these therapiesinfluenceGLP-1metabolic effects by enhancing energy expenditure andfatutilization. They promoteGLP-1weight loss through prolonged satiety, reducing overall intake while preserving muscle mass better than calorie cuts alone.
6 days agoIn recent years,GLP-1medications have become widely discussed in the field of metabolic health and weight management. Originally developed to support individuals with type 2 diabetes,GLP-1therapies are now commonly prescribed by physicians to help regulate appetite and improve metabolic balance. For many people, these medications can create a meaningful shift inhowthe body processes ...
2 days agoGLP-1(glucagon-like peptide1) is a hormone your body naturally produces to regulate blood sugar, control appetite, and supportfatmetabolism. Think of it as your body's built-in weight management system!
TodayTL;DR:GLP-1medications like Ozempic and Wegovy can initially lead to weight loss by reducing hunger and slowing digestion, but weight often plateaus as the body adapts. Factors contributing to weight loss stalls include metabolic slowdown, sneak-in of extra calories, reduced physical activity, tolerance to medication, stress, certain drugs or health issues, and others. To break the plateau ...